Verywell / AstraZeneca
Key Takeaways
Evusheld is no longer authorized for use in the United States.
What Is Evusheld?
Evusheld is a combination of two monoclonal antibodies: tixagevimab and cilgavimab.
Verywell / AstraZeneca
Monoclonal antibodies bind to a specific site on the COVID virus to prevent it from getting into human cells.
The drug was developed by AstraZeneca as pre-exposure prophylaxis for COVID.
For the time being, no other monoclonals are authorized for COVID-19, Sullivan said.
For the most recent updates on COVID-19, visit ourcoronavirus news page.
Centers for Disease Control and Prevention.COVID-19 treatments and medications.
